Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia

University of Maryland, Baltimore

University of Virginia School Of Medicine, Charlottesville

University of South Alabama, Mobile

Regional Obstetrical Consultants, Chattanooga

University Of Mississippi Medical Center, Jackson

Children's Hospital Foundation Building, Louisville

University Hospitals Case Medical Center-Case Western Reserve University (CWRU), Cleveland

University of Cincinnati Medical Center, Cincinnati

Detroit Medical Center (DMC), Detroit

Medical College of Wisconsin, Milwaukee

University of Kansas Medical Center, Kansas City

Louisiana State University Health Sciences Center in New Orleans, New Orleans

Baylor Scott & White Health, Temple

Texas Children's Hospital/Baylor College of Medicine, Houston

The University of Texas Health Science Center at Houston (UTHSC-H), Houston

The University of Texas Medical Branch (UTMB), Galveston

Adalbertus Hospital, Gdansk

Sefako Makgatho Health Sciences University, Pretoria